Opportunity Information: Apply for RFA PS 16 00102CONT17

The Centers for Disease Control and Prevention Minority HIV/AIDS Research Initiative (MARI) grant opportunity is a CDC-sponsored cooperative agreement designed to strengthen HIV prevention, treatment, and research capacity in communities that have been disproportionately affected by HIV, with a specific emphasis on Black and Hispanic populations. A central theme of the initiative is not only improving community-level public health impact, but also expanding the pipeline and leadership of historically underrepresented researchers working in HIV. In practice, the opportunity is aimed at building and sustaining the skills, infrastructure, and partnerships needed to carry out high-quality HIV-related research and to translate findings into real-world prevention and care improvements in the communities facing the highest burden.

This opportunity is listed as a continuation under Funding Opportunity Number RFA PS 16 00102CONT17, meaning it is structured to support ongoing work tied to an existing program framework rather than launching a completely new, one-time project cycle. The funding mechanism is a cooperative agreement, which is important because it typically involves substantial involvement from CDC staff beyond what would be expected in a standard grant. Under cooperative agreements, recipients generally work in closer coordination with CDC on planning, implementation, monitoring, and dissemination. That arrangement usually signals an emphasis on accountability, measurable outcomes, and alignment with CDC priorities and evidence-based public health approaches.

The activity category is Health, and the program is associated with CFDA number 93.941, which is commonly linked to HIV prevention activities and related public health initiatives. While the listing does not provide a dollar-based award ceiling (it shows an award ceiling of 0), it does indicate an expectation of around 10 awards. When a ceiling is not specified in a summary record like this, it often means prospective applicants need to consult the full announcement or continuation guidance for budget limits, allowable costs, and any required matching or leveraging expectations, or it may reflect that the continuation award levels are determined by prior-year funding, negotiated workplans, or appropriations rather than a fixed cap published in the synopsis.

The eligibility category is labeled broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)," which is a common way for federal notices to point applicants to more specific eligibility language in the full announcement. Programs like MARI often focus eligibility around institutions or organizations with demonstrated connections to the target communities and/or capacity-building missions, which can include certain community-based organizations, academic institutions, health departments, or other entities that can credibly support both research training and community-engaged HIV work. The key point is that eligibility is not fully defined in the synopsis provided, so any organization considering applying would need to review the detailed eligibility section to confirm fit.

From a goals and impact standpoint, MARI is framed around two reinforcing needs: first, addressing persistent HIV disparities affecting Black and Hispanic communities through stronger prevention and treatment efforts that are informed by research; and second, improving representation in HIV research by supporting historically underrepresented investigators. That combination suggests the initiative is meant to reduce gaps not only in HIV outcomes (such as incidence, linkage to care, retention in care, and viral suppression), but also in who leads, designs, and benefits from research. Capacity-building in this context typically includes developing research skills, mentorship structures, partnerships with affected communities, data and evaluation capabilities, and organizational systems that allow research to be conducted ethically and effectively. It also often implies a focus on culturally responsive approaches and on strengthening trust and collaboration between researchers, service providers, and community members.

Administratively, the opportunity is offered by the Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), and it appears in the CDC electronic research administration environment (ERA). The record shows a creation date of November 18, 2016, with an original closing date of January 12, 2017, reflecting the timeframe for that cycle of the opportunity. Even though those dates are historical, they are useful for understanding that this is a specific posted announcement and that the continuation framing likely relates to funding and program cycles active during that period.

In plain terms, this funding opportunity is about strengthening the people and systems needed to do effective HIV work where the need is greatest. It supports efforts that improve community-level HIV prevention and treatment capacity while also cultivating and supporting researchers from groups that have been historically underrepresented in HIV research leadership. The cooperative agreement structure signals that CDC expects to be actively engaged with awardees to help ensure the work stays aligned with national HIV prevention priorities, uses sound methods, and produces results that can be applied to reduce disparities.

  • The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Centers for Disease Control and Prevention Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Res" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.941.
  • This funding opportunity was created on Nov 18, 2016.
  • Applicants must submit their applications by Jan 12, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 10 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for RFA PS 16 00102CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

CDC Minority HIV/AIDS Research Initiative (MARI) Grant Opportunity FAQs

What is the CDC Minority HIV/AIDS Research Initiative (MARI) grant opportunity?

MARI is a CDC-sponsored cooperative agreement designed to strengthen HIV prevention, treatment, and research capacity in communities disproportionately affected by HIV. It places specific emphasis on Black and Hispanic populations and aims to improve both community-level public health impact and the pipeline and leadership of historically underrepresented HIV researchers.

What is the main purpose of this funding opportunity?

The opportunity focuses on building and sustaining the skills, infrastructure, and partnerships needed to carry out high-quality HIV-related research and to translate research findings into real-world prevention and care improvements in communities with the highest HIV burden.

How does this opportunity address HIV disparities?

MARI is framed around strengthening prevention and treatment efforts informed by research, with the intent to reduce persistent HIV disparities affecting Black and Hispanic communities. The program is oriented toward improving outcomes that often include measures like incidence, linkage to care, retention in care, and viral suppression (as examples of the types of gaps it aims to reduce).

What does it mean that this is a continuation under Funding Opportunity Number RFA PS 16 00102CONT17?

This listing is described as a continuation under the funding opportunity number RFA PS 16 00102CONT17. That signals it is structured to support ongoing work tied to an existing program framework, rather than launching a completely new, one-time project cycle.

What type of funding mechanism is used?

The mechanism is a cooperative agreement. This typically involves substantial involvement from CDC staff beyond what is expected in a standard grant, with closer coordination on planning, implementation, monitoring, and dissemination.

How is a cooperative agreement different from a standard grant?

Based on the description provided, cooperative agreements generally require recipients to work in closer coordination with CDC staff than under a standard grant. This arrangement often signals an emphasis on accountability, measurable outcomes, and alignment with CDC priorities and evidence-based public health approaches.

Which agency and department are offering this opportunity?

The opportunity is offered by the Department of Health and Human Services (HHS) through the Centers for Disease Control and Prevention (CDC).

What is the activity category for this opportunity?

The activity category is Health.

What is the CFDA number associated with this program?

The program is associated with CFDA number 93.941, which is commonly linked to HIV prevention activities and related public health initiatives.

How many awards are expected?

The listing indicates an expectation of around 10 awards.

Is there an award ceiling or maximum funding amount listed?

The summary record shows an award ceiling of 0, meaning a dollar-based ceiling is not specified in the synopsis provided.

If the award ceiling is not specified, how should applicants interpret the budget expectations?

When a ceiling is not specified in a summary record like this, it often means applicants need to consult the full announcement or continuation guidance for budget limits, allowable costs, and any matching or leveraging expectations. It may also reflect that continuation award levels are determined by prior-year funding, negotiated workplans, or appropriations rather than a fixed cap published in the synopsis.

Who is eligible to apply?

The eligibility category is listed broadly as "Others (see text field entitled Additional Information on Eligibility for clarification)." The synopsis does not fully define eligibility, so organizations would need to review the detailed eligibility section in the full announcement to confirm fit.

What kinds of organizations might be a good fit for MARI, based on the synopsis?

While the synopsis does not define eligibility, it notes that programs like MARI often focus eligibility around institutions or organizations with demonstrated connections to the target communities and/or capacity-building missions. Examples mentioned include certain community-based organizations, academic institutions, health departments, or other entities that can credibly support both research training and community-engaged HIV work.

What populations are emphasized in this initiative?

The initiative specifically emphasizes communities disproportionately affected by HIV, with particular focus on Black and Hispanic populations.

Does MARI focus only on community impact, or also on research workforce development?

It explicitly focuses on both. A central theme is improving community-level public health impact while also expanding the pipeline and leadership of historically underrepresented researchers working in HIV.

What does "capacity-building" mean in the context of this opportunity?

Capacity-building in this context typically includes developing research skills, mentorship structures, partnerships with affected communities, data and evaluation capabilities, and organizational systems needed to conduct research ethically and effectively. It also often implies culturally responsive approaches and strengthening trust and collaboration among researchers, service providers, and community members.

What kinds of activities are implied by the focus on translating findings into practice?

The synopsis emphasizes translating research findings into real-world prevention and care improvements. This suggests an expectation that funded work not only generates knowledge, but also supports application of findings to improve HIV prevention and treatment efforts in high-burden communities.

What does the synopsis suggest about CDC's role during the project?

Because this is a cooperative agreement, the synopsis indicates CDC expects to be actively engaged with awardees, including involvement in planning, implementation, monitoring, and dissemination to help ensure alignment with national HIV prevention priorities and sound methods.

Where is this opportunity administered or submitted through?

The record indicates it appears in the CDC electronic research administration environment (ERA).

What are the key dates shown for this opportunity?

The record shows a creation date of November 18, 2016, with an original closing date of January 12, 2017.

Are those dates current?

The dates shown are historical for that posted cycle. The synopsis notes that even though the dates are historical, they help identify this as a specific posted announcement and reinforce the continuation framing tied to program cycles active during that period.

What are the overarching outcomes this initiative is trying to influence?

The synopsis frames the initiative as reducing gaps in HIV outcomes and reducing gaps in who leads, designs, and benefits from research. It emphasizes stronger prevention and treatment efforts informed by research and increased representation and leadership among historically underrepresented investigators.

What does the synopsis imply about performance expectations?

The cooperative agreement structure is described as typically involving accountability, measurable outcomes, and alignment with CDC priorities and evidence-based public health approaches, suggesting recipients should expect a structured relationship with monitoring and results-oriented expectations.

Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA

Browse more opportunities from the same category: Health

Next opportunity: U.S. Embassy Windhoek PAS Annual Program Statement

Previous opportunity: R2 Sport Fish Restoration Grant Program FOR STATE FISH AND GAME AGENCIES

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA PS 16 00102CONT17

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA PS 16 00102CONT17) also looked into and applied for these:

Funding Opportunity
Addressing Emerging Zoonoses and Strengthening Animal and Human Health Systems Apply for CDC RFA CK17 1702

Funding Number: CDC RFA CK17 1702
Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID
Category: Health
Funding Amount: Case Dependent
Medical Monitoring Project (MMP) Apply for CDC RFA PS15 150303CONT17

Funding Number: CDC RFA PS15 150303CONT17
Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP
Category: Health
Funding Amount: Case Dependent
Integrated Approaches to HIV-Related Heart, Lung, Blood, and Sleep (HLBS) Comorbidities (R01) Apply for RFA HL 18 004

Funding Number: RFA HL 18 004
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $499,999
Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24) Apply for RFA RM 16 018

Funding Number: RFA RM 16 018
Agency: Department of Health and Human Services, National Institutes of Health
Category: Health
Funding Amount: $2,000,000
USAID/Haiti Request for Information on programming to improve the health status of communities across Haiti. Apply for RFI 521 17 000001

Funding Number: RFI 521 17 000001
Agency: Agency for International Development, Haiti USAID-Port Au Prince
Category: Health
Funding Amount: Case Dependent
Strengthening Surveillance in Jurisdictions with High Incidence of Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Infections Apply for CDC RFA PS17 1703

Funding Number: CDC RFA PS17 1703
Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP
Category: Health
Funding Amount: $350,000
Autism CARES Act National Interdisciplinary Training Resource Center Apply for HRSA 17 010

Funding Number: HRSA 17 010
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally, Center for Global Health Apply for CDC RFA GH15 163202CONT17B

Funding Number: CDC RFA GH15 163202CONT17B
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
National Maternal and Child Center for Oral Health Systems Integration and Improvement Apply for HRSA 17 086

Funding Number: HRSA 17 086
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Support for Health System Strengthening of Leadership, Governance and Quality Improvement in the Ministry of Health (MOH) in the Kingdom of Swaziland under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 158403CONT17

Funding Number: CDC RFA GH15 158403CONT17
Agency: Department of Health and Human Services, Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Natural Experiments of Policy and Built Environment Impact on Diabetes Risk Apply for RFA DP 17 003

Funding Number: RFA DP 17 003
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $675,000
Miner Safety and Health Training Program-Western United States (U60) Apply for RFA OH 17 006

Funding Number: RFA OH 17 006
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $400,000
Conducting Public Health Activities in Egypt Apply for RFA GH 17 004

Funding Number: RFA GH 17 004
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $2,000,000
Methamphetamine and Suicide Prevention Initiative - Generation Indigenous (Gen-I) Initiavite Support Apply for HHS 2017 IHS MSPI 0001

Funding Number: HHS 2017 IHS MSPI 0001
Agency: Department of Health and Human Services, Indian Health Service
Category: Health
Funding Amount: $400,000
Autism Transitions Research Project (ATRP) Apply for HRSA 17 097

Funding Number: HRSA 17 097
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Frontier Community Health Integration Project Technical Assistance, Tracking, and Analysis Program Apply for HRSA 17 001

Funding Number: HRSA 17 001
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Research Grants for Preventing Violence and Violence Related Injury (R01) Apply for RFA CE 17 003

Funding Number: RFA CE 17 003
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $350,000
Increasing Organ Donation Awareness Apply for HRSA 17 104

Funding Number: HRSA 17 104
Agency: Department of Health and Human Services, Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Addiction Technology Transfer Centers Cooperative Agreement (Short Title: ATTC) Apply for TI 17 005

Funding Number: TI 17 005
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Admin
Category: Health
Funding Amount: $1,175,294
Community Characteristics Associated with Geographic Disparities in Diabetes and Cardiometabolic Health Apply for RFA DP 17 001

Funding Number: RFA DP 17 001
Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $800,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA PS 16 00102CONT17", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: